In addition to the pathological Gleason Grade Group (GGG) assessed in prostate biopsies (Bx), other variables such as age, prostate-specific antigen (PSA), clinical stage, and biopsy-based tumor volume have been used to predict postoperative tumor characteristics of an individual PC patient [1–5]. This evidence concerns the gene KLK3 and pachyonychia congenita.